Abstract

BackgroundIn the past, molecular mechanisms that drive the initiation of an inflammatory response have been studied intensively. However, corresponding mechanisms that sustain the expression of inflammatory response genes and hence contribute to the establishment of chronic disorders remain poorly understood. Recently, we provided genetic evidence that signaling via the receptor for advanced glycation end products (Rage) drives the strength and maintenance of an inflammatory reaction. In order to decipher the mode of Rage function on gene transcription levels during inflammation, we applied global gene expression profiling on time-resolved samples of mouse back skin, which had been treated with the phorbol ester TPA, a potent inducer of skin inflammation.ResultsRanking of TPA-regulated genes according to their time average mean and peak expression and superimposition of data sets from wild-type (wt) and Rage-deficient mice revealed that Rage signaling is not essential for initial changes in TPA-induced transcription, but absolutely required for sustained alterations in transcript levels. Next, we used a data set of differentially expressed genes between TPA-treated wt and Rage-deficient skin and performed computational analysis of their proximal promoter regions. We found a highly significant enrichment for several transcription factor binding sites (TFBS) leading to the prediction that corresponding transcription factors, such as Sp1, Tcfap2, E2f, Myc and Egr, are regulated by Rage signaling. Accordingly, we could confirm aberrant expression and regulation of members of the E2f protein family in epidermal keratinocytes of Rage-deficient mice.ConclusionsIn summary, our data support the model that engagement of Rage converts a transient cellular stimulation into sustained cellular dysfunction and highlight a novel role of the Rb-E2f pathway in Rage-dependent inflammation during pathological conditions.

Highlights

  • In the past, molecular mechanisms that drive the initiation of an inflammatory response have been studied intensively

  • The gene fold expression was calculated with respect to nontreated controls (0 h), and TPA-responsive genes in samples of wt back skin were ranked according to their combined averaged mean and peak expression within the experimental time window of 48 hours for each individual kinetic series

  • When we considered the transcript levels of these genes in receptor for advanced glycation end products (Rage)-/- back skin and superimposed both wt and Rage-/- data sets we found a comparable response in both genotypes at 6 hours

Read more

Summary

Introduction

Molecular mechanisms that drive the initiation of an inflammatory response have been studied intensively. Corresponding mechanisms that sustain the expression of inflammatory response genes and contribute to the establishment of chronic disorders remain poorly understood. We provided genetic evidence that signaling via the receptor for advanced glycation end products (Rage) drives the strength and maintenance of an inflammatory reaction. Several lines of evidence, including population-based epidemiological and clinical studies as well as experimental animal model systems, highlighted chronic infection and persistent inflammation as major risk factors for various types of cancer [1,2]. We could show that the receptor for advanced glycation end products (Rage) drives the strength and maintenance of inflammation during tumor promotion in a mouse model of inflammationassociated skin carcinogenesis [3]. Rage expression increases at sites of inflammation, mainly on inflammatory cells, endothelial cells and epithelial cells, and propagates cellular dysfunction in numerous inflammation-related pathological states, such as diabetes, vascular disease, neurodegeneration, chronic inflammation, and cancer [5,6,7]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.